Sign In
Buy CRC
$52.90
-1.91 (-3.48%)
At Close: Jun 23, 2026
California Resources Corporation Announces Pricing of Private Offering of $550 Million of Senior Unsecured Notes
05:11pm, Tuesday, 16'th Jun 2026
LONG BEACH, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (the “Company”) announced today the pricing of its private offering of $550 million in aggregate
California Resources Corporation Announces Private Offering of $550 Million of Senior Unsecured Notes
08:21am, Tuesday, 16'th Jun 2026
LONG BEACH, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (the “Company”) announced today that, subject to market and other conditions, it intends to offer
California Resources: The Winds Of Change In California Finally
06:12am, Sunday, 14'th Jun 2026
California Resources stands to benefit from regulatory compromise enabling thousands of new wells in Kern County while tightening offshore restrictions. CRC's merger with Berry Corporation enhances op
Why Is California Resources (CRC) Up 1.2% Since Last Earnings Report?
12:36pm, Thursday, 04'th Jun 2026
California Resources (CRC) reported earnings 30 days ago. What's next for the stock?
Consolidation Wave Reshapes Energy Sector: 3 Stocks Vulnerable to Acquisition, Ranked
11:20am, Thursday, 04'th Jun 2026
Energy sector consolidation has accelerated through 2026 so far, with majors and large independents acquiring scale, inventory, and strategic infrastructure.
Here's Why California Resources Corporation (CRC) is a Strong Momentum Stock
10:51am, Thursday, 04'th Jun 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
09:00am, Sunday, 31'st May 2026
[url="]Pfizer Inc. [/url](NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 B
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
09:00am, Saturday, 30'th May 2026
Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
08:00am, Friday, 29'th May 2026
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON,
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi
California Resources Starts First CO2 Injection at CCS Facility
11:14am, Wednesday, 27'th May 2026
CRC announces California's first operational carbon capture project, advancing large-scale CO2 storage and expanding the state's climate strategy.
American Cancer Society Recommends Guardant Health's Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
08:00am, Wednesday, 27'th May 2026
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its FDA-approved Shield⢠blood test is now included in updated Ameri
KERN COUNTY, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) has achieved the first landmark carbon dioxide (CO2) injection at Carbon TerraVault I (CTV I), a firs
Is California Resources (CRC) Stock Outpacing Its Oils-Energy Peers This Year?
10:40am, Monday, 18'th May 2026
Here is how California Resources Corporation (CRC) and ConocoPhillips (COP) have performed compared to their sector so far this year.
California Resources Q1 Earnings Beat on Strong Oil Prices
09:26am, Monday, 11'th May 2026
CRC beat Q1 adjusted EPS and revenues on strong oil pricing, even as a massive derivative mark-to-market loss pushed GAAP results into the red.
